As one of the world’s leading specialty ophthalmology companies, Santen carries out research, development, marketing, and sale of pharmaceuticals, over-the-counter products, and medical devices.
In Japan, Santen is the market leader for prescription ophthalmic pharmaceuticals and has a strong presence in Asia and Asia Pacific with direct operations established in several countries as well as with distributor partners. Also, it has been active in the European market since 1994 and is enjoying steady growth in EMEA (Europe, Middle East and Africa). Santen has major sites throughout the world and its products are now reaching patients in over 60 countries. With cultivated scientific knowledge and organizational capabilities nurtured over a 130-year history, Santen provides products and services to contribute to the well-being of patients, their loved ones and consequently to the society.
This year, Santen has set a new long-term vision, aiming to become a “social innovator”. In this vision, we have described WORLD VISION, “Happiness with Vision” which indicates that we will strongly pursue the Happiest Life for every individual, through the Best Vision Experience. In order to achieve this WORLD VISION, we have also formulated Santen 2030, showing what we aspire to be in 2030 and beyond. As there are still many countries and regions in the world where ophthalmic treatments are not sufficiently available and where medical needs are unmet, Santen is truly dedicated with People-Centric mind to achieve our goal to reduce the loss of social and economic opportunities for people around the world due to visual impairments or blindness and to help to realize the people’s happiness. At Santen, we devote ourselves not only to develop innovative pharmaceutical technologies but also to accelerate the ecosystem development, raise people’s awareness toward better eye condition, and build society that is inclusive regardless of visual impairment.